Retatrutide 20mg Dosage Protocol

1. Preparation and Measurement

Retatrutide 20mg With 2mL of Diluent

Add 2mL of bacteriostatic water to the vial. The resulting concentration is 10mg/mL. On a U-100 syringe, each unit contains 100mcg.

Preparation

1. Draw 2mL of bacteriostatic water using sterile equipment.
2. Let the liquid run slowly down the inside wall of the vial.
3. Gently swirl until dissolved. Do not shake.
4. Label with the preparation date and refrigerate.

Check the calculation with the peptide calculator.

2. Commonly Documented Schedule

Route commonly described: subcutaneous in phase 2 research. Frequency: once weekly.

Vial estimate: One 20mg vial contains approximately 10 administrations at the first listed amount or 1 at the final listed amount.

Practical Notes

• The table applies only to this vial prepared with exactly 2mL.
• An asterisk marks measurements above 1mL, which exceed the capacity of a standard 1mL U-100 syringe.
• Record the amount, date, and preparation used.

3. Supplies Needed

• Retatrutide 20mg vial.
• 2mL of bacteriostatic water per vial.
• Sterile U-100 syringes.
• Alcohol swabs.
• Sharps container.

4. Storage and Handling

• Keep unopened vials cool, dry, dark, and protected from moisture.
• After preparation, refrigerate at 2-8 degrees C.
• Protect from light and avoid repeated freeze-thaw cycles.
• Do not use material with particles, discoloration, or a damaged seal.

5. Research Context

Retatrutide is an investigational triple receptor agonist studied in phase 2 trials. It is not an approved medicine, and later-stage research may use different designs or conclusions.

The table records a phase 2-style escalation for educational comparison. It is not a prescribing schedule or evidence that a laboratory vial is suitable for human use.

Primary Research and Regulatory References

1. Retatrutide phase 2 obesity trial
2. Retatrutide phase 2 diabetes trial
3. Retatrutide phase 2 trial registry